← Open Payments lookup

HY PHAN: Open Payments

NPI 1144373408 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$678 in 27 payments from 10 companies in 2025. Trend: 2023 $1,126 · 2024 $1,099 · 2025 $678

Food & beverage: $600Education: $78
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.5$152
Otsuka America Pharmaceutical, Inc.6$135
Teva Pharmaceuticals USA, Inc.2$97
E.R. Squibb & Sons, L.L.C.4$83
Janssen Pharmaceuticals, Inc3$53
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$50
Alkermes, Inc.2$42
ABBVIE INC.1$26
Axsome Therapeutics, Inc.1$23
Lundbeck LLC1$18

Products named: INGREZZA, REXULTI, COBENFY, INVEGA SUSTENNA, CAPLYTA, ARISTADA, VRAYLAR, Auvelity.

Industry payments across CA — which companies pay providers there.